1. Phase I/II trial of the combination of midostaurin (PKC412) and 5‐azacytidine for patients with acute myeloid leukemia and myelodysplastic syndrome. Issue 4 (2nd March 2015) Authors: Strati, Paolo; Kantarjian, Hagop; Ravandi, Farhad; Nazha, Aziz; Borthakur, Gautam; Daver, Naval; Kadia, Tapan; Estrov, Zeev; Garcia‐Manero, Guillermo; Konopleva, Marina; Rajkhowa, Trivikram; Durand, Menda; Andreeff, Michael; Levis, Mark; Cortes, Jorge Journal: American journal of hematology Issue: Volume 90:Issue 4(2015:Apr.) Page Start: 276 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Targeting FLT3 to treat leukemia. (January 2015) Authors: Konig, Heiko; Levis, Mark Journal: Expert opinion on therapeutic targets Issue: Volume 19:Number 1(2015:Jan.) Page Start: 37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗